MedTrace Logo

Impact of Humeral Component Version on Outcomes Following RTSA

NCT03111147 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2024-03-05

Study results available
· View outcomes & findings →

Summary

The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.

Conditions

  • Rotator Cuff Tear Arthropathy

Interventions

DEVICE

0 degrees humeral component version

RTSA with humeral component positioned in 0 degrees of version

DEVICE

30 degrees humeral component retroversion

RTSA with humeral component positioned in 30 degrees of retroversion

Sponsors & Collaborators

  • William Beaumont Hospitals

    lead OTHER

Principal Investigators

  • J. Michael Wiater, MD · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-12
Primary Completion
2023-05-23
Completion
2023-05-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03111147 on ClinicalTrials.gov